NCT01480778View on ClinicalTrials.gov

Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Irregular Periods
Interventions
DRUG

LNG+EE2

Administration of one pill contained 0.15 mg of levonosgestrel and 0.03 mg of ethynil estradiol per day over 21 days.

DRUG

Nordette

Administration of one pill contained 0.15 mg of levonosgestrel and 0.03 mg of ethynil estradiol per day over 21 days.

Trial Locations (1)

Unknown

LAL Clínica Pesquisa e Desenvolvimento Ltda, Valinhos

All Listed Sponsors
collaborator

União Química Farmacêutica Nacional S/A

INDUSTRY

lead

Azidus Brasil

INDUSTRY

NCT01480778 - Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®. | Biotech Hunter | Biotech Hunter